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Abstract
Tau hyperphosphorylation can be considered as one of the hallmarks of Alzheimer’s disease and other tauophaties. Besides
its well-known role as a microtubule associated protein, Tau displays a key function as a protector of genomic integrity in
stress situations. Phosphorylation has been proven to regulate multiple processes including nuclear translocation of Tau. In
this contribution, we are addressing the physicochemical nature of DNA-Tau interaction including the plausible influence of
phosphorylation. By means of surface plasmon resonance (SPR) we measured the equilibrium constant and the free energy,
enthalpy and entropy changes associated to the Tau-DNA complex formation. Our results show that unphosphorylated Tau
binding to DNA is reversible. This fact is in agreement with the protective role attributed to nuclear Tau, which stops
binding to DNA once the insult is over. According to our thermodynamic data, oscillations in the concentration of
dephosphorylated Tau available to DNA must be the variable determining the extent of Tau binding and DNA protection. In
addition, thermodynamics of the interaction suggest that hydrophobicity must represent an important contribution to the
stability of the Tau-DNA complex. SPR results together with those from Tau expression in HEK cells show that
phosphorylation induces changes in Tau protein which prevent it from binding to DNA. The phosphorylation-dependent
regulation of DNA binding is analogous to the Tau-microtubules binding inhibition induced by phosphorylation. Our results
suggest that hydrophobicity may control Tau location and DNA interaction and that impairment of this Tau-DNA
interaction, due to Tau hyperphosphorylation, could contribute to Alzheimer’s pathogenesis.
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Introduction
Tau is a microtubule associated protein. It participates in the
microtubule stabilization and organization system which regulates
cellular morphogenesis, cytoskeleton functionality and axonal
transport [1–6]. Alternative splicing gives rise to six isoforms
expressed from the same gene in the CNS [7]. Tau protein
contains a large number of serine and threonine phosphorylation
sites. Hyperphosphorylation can be considered as one of the
hallmarks of Alzheimer’s diseases and other tauophaties [1,8–11].
Together with the extracellular senile plaques, the intracellular
tangles composed mainly of Tau protein, forming the paired
helical filaments (PHFs), are the second type of aberrant
proteinaceous aggregates found associated to Alzheimer’s disease
[12–15]. Tau is a highly soluble protein devoid of any well-defined
secondary or tertiary structure, as many other proteins prone to
aggregation and fibrillization also involved in neurodegenerative
diseases. A survey of Tau literature leads one to conclude that
aggregation and hyperphosphorylation must have a particular role
in the neurodegenerative processes [16,17]. However, a precise
knowledge of those particular molecular events involving Tau
protein in Alzheimer’s disease yet remains elusive.
The interaction of Tau protein with DNA in vitro [18–23] and
in situ, in neuronal [24] and non-neuronal [25] cells has been
repeatedly reported. Although this protein is mainly found in the
cytosol of neuronal cells, it has also been localized within the
nucleus of neuronal [24,26–31] and non-neuronal cells [25,32–
34]. Tau protein has also been found localized at ribosomes and
plasma membrane of neuronal cells [35,36]. The post-translational
modification of the different isoforms of Tau together with its
complex distribution in different cellular locations suggests a
multifunctional role for this protein. Results concerning the Tau-
microtubule interaction suggest that phosphorylation is involved in
the regulation of Tau function. It was long time ago reported that
phosphorylation produces a diminution in the affinity of Tau for
the microtubule lattice [37,38]. More recently, Tau phosphory-
lation by GSK3 has been reported to affect its axonal transport
[39,40]. Many other Tau functions such as interneuronal
signaling, mitochondrial mobility or interaction with synaptic
proteins have also been reported to be affected by phosphorylation
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(see reference [41] for review). Therefore we would say that Tau
phosphorylation seems to be the general mechanism by which Tau
function is regulated.
As for the nuclear location, studies on non-neuronal cells confer
Tau an important role in nucleolar structure conformation and
heterochromatinization of ribosomal genes [25,34]. The role that
it might play in the nucleus of neurons remains, however, to be
elucidated, as well as the plausible physiological consequences
derived from its interaction with DNA. A function related to
protection of genomic integrity has been recently assigned to Tau
protein [24]. These authors report that, similarly to the reversible
nuclear translocation associated to dephosphorylation of many
transcription factors (see [42] and references inside), oxidative or
heat stress induce accumulation of dephosphorylated Tau protein
within the nuclei of neurons. In addition, that nuclear transloca-
tion of Tau correlates with an increase of Tau-DNA interaction
and DNA protection from heat stress damage [24]. In agreement
with this observation, a recent report from our laboratory
describes how Tau confers thermodynamic stability properties to
DNA which are similar to those provided by histone, as deduced
from in vitro experiments [43]. Similarly to the Tau-microtubule
interaction, nuclear translocation of Tau is also regulated by
phosphorylation, as many other Tau functions. However, the
influence that phosphrylation may exert on the Tau-DNA
interaction still remains unclear. Hua and He reported that
phosphorylation of Tau with cdc2-like kinases did not affect the
interaction with DNA [44]. A recent publication of Lu et al,
however, describes how phosphorylation prevents Tau from DNA
binding [45].
It seems that Tau translocation and the subsequent DNA
binding and protection is reversible. It means that Tau binding to
DNA must be controlled by the concentration inside the nucleus.
The results we present here prove that, similarly to the Tau-
microtubules interaction, Tau-DNA interaction is indeed depen-
dent on the phosphorylation state of the protein, as shown by
surface plasmon resonance and Tau expression in human
embryonic kidney 293 (HEK) cells. Unphosphorylated, weakly
aggregated forms of Tau, bind DNA reversibly, strengthening the
concept of a functional regulatory role for Tau protein. The results
of this reversible interaction characterized by means of surface
plasmon resonance, allowed us to measure DG, DH and DS
values, which suggest hydrophobicity must represent an important
contribution to the Tau-DNA stability complex. Hyperphosphor-
ylation of Tau could impair this interaction, therefore contributing
to the Alzheimer’s pathogenesis.
Results
Tau expression in HEK cells gives rise to phosphorylation
in proliferating cells
Figure 1 shows the DNA and Tau localization in human
embryonic kidney (HEK) cells expressing Tau protein in a stable
form. Immunofluorescent confocal microscopy was used to study
the distribution of both molecules in different populations of these
cells. Staining with Tau5, an antibody which recognizes both
phosphorylated and unphosphorylated forms of the protein, shows
that Tau is mainly located in the cytosol of non-dividing cells
(Fig. 1A). Nevertheless, Tau is also present inside the nuclei,
although it seems to represent a minor proportion of total Tau. On
the other hand, there are some To-Pro-3-labeled cells that have
been pictured in the middle of division, displaying a highly
condensed DNA (see Fig. 1A, TOPRO). In these cases where
nuclear membrane disappears, certain proportion of labeled Tau
protein (see arrows within Fig. 1A) share the same regions
occupied by chromosomes, suggesting that a fraction of Tau
colocalizes with DNA at some stages of cell division. A distinction
between DNA (red in gray scale) and Tau (green in gray scale)
starts to show up, still indicating that a fraction of Tau does not
colocalize with DNA.
In Fig. 1B, PHF-1 antibody recognizes Tau molecules which
are phosphorylated in serine 396 and 404. It can be observed that,
as chromosomes starts to condensate in replicating cells, there is a
clear distinction between DNA (red in gray scale) and phosphor-
ylated Tau (green in gray scale). Interestingly, PHF-1 signal
increases when the division process is started, what means that
most of Tau recognized by Tau5 antibody must be progressively
phosphorylated from the onset of cell cycle by nuclear kinases. The
fact that phosphorylated Tau does not colocalize with condensed
chromosomes in those situations where nuclear membrane
disappears, suggests that phosphorylation would play a putative
role preventing Tau-DNA interaction in replicating cells, similarly
to the previously described microtubule binding inhibition induced
by phosphorylation [37,38].
Effect of phosphorylation on the Tau-DNA interaction in
vitro
Tau-DNA interaction in vitro was studied by flowing Tau
solutions on a DNA activated sensor surface assembled on a
surface plasmon resonance instrument. As it can be seen in part A
of Figure 2, the unphosphorylated form of Tau binds DNA, as we
have previously reported [43]. The reflectance-increase observed
after injecting the Tau solution denotes the DNA-binding of the
unphosphorylated form of Tau, purified from expression in E.coli.
Phosphorylated Tau-42 expressed in Sf9 cells only shows a small
interaction with DNA, as can be seen in part A of Figure 2. The
negative charge supplied by the phosphate groups are plausibly the
cause of this loss of DNA binding capability showed by the
phosphorylated form of Tau. Part B of the same Figure bears out
it. As compared to the unphosphorylated form of Tau, the
phosphorylated form also shows a small interaction with heparin.
Figure 1. Confocal micrographs of Tau-stably expressed HEK-
293 cells immunostained using PHF-1 and Tau-5 antibodies.
Left column (green in grey scale) corresponds to Tau-5 (A, total Tau)
and PHF-1 (B, phosphorylated Tau). Central column (red in grey scale)
shows To-Pro-3 labeling (DNA). Right column shows merge images.
Scale bar is equal to 10 mm.
doi:10.1371/journal.pone.0104690.g001
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Basic amino acids of phosphorylated Tau form might be
responsible of these residual interactions with heparin and DNA.
Part C of the same Figure supports this. A mixture composed of
DNA and histone was immobilized on the sensor surface.
Unphosphorylated form of Tau is readily immobilized on this
surface. However, the phosphorylated form does not bind this
histone-DNA complex. The previously shown residual binding of
phosphorylated Tau to DNA disappeared. These results suggest
that Tau may be phosphorylated on those sites closely related to
the interaction with DNA.
The loss of interaction with DNA induced by Tau phosphor-
ylation does not seem to be related to dramatic changes in the
aggregation state of the protein. The UV spectrum does not show
the acute light scattering profile usually found for large aggregating
protein forms (see Figures S1 and S2 in File S1). Besides that,
phosphorylated Tau could be bound to polylysine activated
surfaces, displaying a layer thickness slightly larger than that for
Figure 2. Effect of phosphorylation on the DNA-Tau protein
interaction. Part A: Tau protein (12 mg/mL) (T) and phosphorylated
Tau (12 mg/mL) (PT) binding to a DNA activated sensor surface (D). Part
B: Tau protein (10 mg/mL) (T) and phosphorylated Tau (10 mg/mL) (PT)
binding to the heparin activated sensor surface (H). Part C: Tau protein
and phosphorylated Tau binding to a DNA-histone mixture immobilized
on the sensor surface. DNA (8 mg/mL) was incubated with histone
(8 mg/mL) for one hour. At the time indicated by C, the incubated
mixture was flowed on a heparin activated surface. Tau protein (T) and
phosphorylated Tau (PT), both at 10 mg/mL, were then flowed through
the sensor cell. All phosphorylated Tau forms were flowed during at
least 10 minutes, which is enough for the full binding of Tau protein in
Figures 2A and 2B, and for more than 60% in Figure 2C.
doi:10.1371/journal.pone.0104690.g002
Figure 3. Reversible binding of Tau protein to DNA immobi-
lized on the sensor surface. Part A: Reflectance time-course of the
interaction. Solutions were injected at the time indicated by arrows:
8 mg/mL DNA and18 mg/mL Tau protein. RB stands for running buffer.
Parts B and C show the kinetic analysis of the association and
dissociation processes respectively.
doi:10.1371/journal.pone.0104690.g003
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the unphosphorylated form (Figure S3 in File S1), which indicates
that oligomers within the range of 1 to 2 nm can be formed but no
large fibrillar aggregates.
The thermodynamics of the unphosphorylated Tau-DNA
interaction, as probed by Surface Plasmon Resonance
As shown in part A of Figure 3, the reflectance-increase value
derived from the Tau-DNA interaction results to be close to that
reflectance-increase value corresponding to the last polylysine
layer of the PHP structure routinely used in the sensor surface
activation. This means that, according to the reported thickness
value of the polylysine layer [46], the reflectance-increase observed
when Tau is flowed on DNA must correspond to the building of a
Tau layer on DNA, mainly composed of unfolded monomers or
small Tau oligomers about 1 nm thick. Tau binding to DNA is
reversible. Part A of Figure 3 shows how the binding of Tau to
DNA is followed by the dissociation of the complex, when running
buffer is injected to flow through the sensor cell. The detailed time
dependence of complex formation as well as the complex
dissociation are shown in parts B and C of the same Figure.
Table 1. Kinetic constants for the Tau-DNA complex formation (k1) and complex dissociation (k21) and the corresponding
equilibrium constants, obtained as k1/k21, at different temperatures.
Temperature (6C) k21 (min21) k161026 (M21min21) Keq61027 (M21)
13 0.17 5 2.9
15 0.13 5 3.8
18 0.27 4 1.5
19 0.22 3.3 1.5
21 0.36 5.3 1.5
21 0.14 4.8 3.4
22 0.24 5.2 2.2
22 0.15 6.1 4.1
26 0.4 7.4 1.8
32 0.32 3.2 1
33 0.33 4.9 1.4
doi:10.1371/journal.pone.0104690.t001
Figure 5. Van’t Hoff plot: temperature dependence of equilib-
rium constant for the Tau-DNA interaction. Equilibrium constants
values were obtained from the quotient k1/k21, where k1 and k21 are
the rate constants obtained from the kinetic analysis (Table 1).
doi:10.1371/journal.pone.0104690.g005
Figure 4. Equilibrium binding of Tau protein to DNA immobi-
lized on the sensor surface. Part A: Reflectance time-course after
flowing Tau protein solutions at different concentrations in mg/mL: 16
(N), 12 (&), 10 (m), 6 (.). Part B: inverse plot of the concentration
dependency of the fractional saturation (equation [10]).
doi:10.1371/journal.pone.0104690.g004
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Analysis of the dissociation process following a first order kinetics
yields the first-order constant k-1. Analysis of the complex
formation following a pseudo-first order kinetics, as described
under Materials and Methods, yields then the second order rate
constant, k1 (inset of part B). Quotient of constants, k1/k-1, renders
the equilibrium constant for the Tau-DNA complex formation,
Keq = (2.4 6 0.4) 10
7 M21 (6 SEM), obtained as the average
from six determinations between 18 uC and 22 uC. This
equilibrium constant is calculated under the assumption of the
simple mechanism of interaction described in Materials and
Methods for the Tau-DNA complex formation. As can be
observed in part A of Figure 4, increasing concentration values
of Tau in those solutions flowing through the sensor cell give rise
to increasing surface saturation. It means that the DNA-activated
sensor surface is saturated by running Tau, in a concentration
dependent manner, due to the reversibility of the interaction. The
saturation fraction, Y, can then be obtained from equation (11) as
a function of the Tau protein concentration (equation 10). An
inverse plot of this hyperbolic equation renders a straight line from
which the Equilibrium Constant for the complex formation, Keq
= (2.3 6 0.6) 107 is obtained.
The Equilibrium Constant value calculated from equilibrium
data does not depend on any kinetic assumption and agrees well
with that value obtained previously from the kinetic model, Keq =
(2.4 6 0.4) 107 M21, therefore supporting the one-step mecha-
nism of interaction proposed in the Materials and Methods
section. The kinetic model used to obtain the rate constants for the
complex formation and dissociation, k1 and k21, was then used to
study the dependency of Equilibrium Constants values on
temperature, within the range of 13uC to 33 uC. The results,
including those obtained between 18 uC and 22 uC are included in
Table 1. It can be seen that Equilibrium Constant for the complex
Tau-DNA barely changes within the selected range of tempera-
ture. A Vant’Hoff plot of the temperature dependency within this
range (Figure 5) renders an enthalpy change for the complex
formation, DHu = 232 6 15 kJ mol21. The potential energy
decrease associated to Tau-DNA complex formation is given by
DGu = 2 RT ln Keq = 241.4 6 0.5 kJ mol21 at 20 uC.
Accordingly, the entropy change, following DSo = (DHo 2 DGo)/
T, results to be close to zero, DSu = 0.03 6 0.05 kJmol21K21.
Tau protein lacks of a well-defined secondary or tertiary structure
in solution. It means that Tau may adopt a huge number of
possible conformations for the polypeptide chain, each of them
housing, in turn, a huge number of quantum states. Therefore,
immobilization of Tau on the DNA molecule would have to
involve a decrease in the number of quantum states available to
Tau, with the corresponding large decrease of entropy. The
positive, almost null value for the entropy variation obtained
suggests that, together with the large diminution of entropy
derived from the Tau immobilization on DNA, there must be a
compensating large increase in the number of quantum states
accompanying the Tau-DNA complex formation. This entropy
increase may have its origin in the release of water molecules
which would confer a strongly hydrophobic character upon the
Tau-DNA complex formation.
Discussion
We describe here the interaction of unphosphorylated Tau with
calf thymus DNA, immobilized on a sensor surface. It has been
shown to be reversible and, according to the reflectance value
increase, mostly attributable to monomeric or small oligomeric
forms of the protein. Surface plasmon resonance supplies
interaction data in real time. It allows therefore the quantitative
analysis of the interaction from a kinetic point of view. The second
order rate constant for the association of Tau with DNA, k1, and
the first-order rate constant for the complex dissociation, k21, can
be obtained from the time-dependency analysis of the reflectance
changes registered. Equilibrium constant for the complex forma-
tion, Keq = k1/k 21 M
21, can then be calculated on the
assumption of the simple mechanism described in Materials and
Methods. On the other hand, the reversibility of the interaction
offers the possibility of obtaining the equilibrium constant from
data concerning the equilibrium fractional saturation, indepen-
dently of any assumption on the interaction mechanism. Both
equilibrium constants values, the one obtained from kinetic data
and that from equilibrium saturation are in good agreement,
therefore confirming the simple one-step mechanism of interac-
tion, as well as the absence of any kind of cooperativity within the
experimental error of our measurements. The dissociation
constant value obtained, Kd = 0.04 mM, means that Tau binds
DNA with a comparable affinity to that shown for the binding to
microtubules, Kd = 0.1 mM as reported by Ackmann et al [47]. A
reversible binding of Tau to DNA has also been described by
Krylova et al [22], as obtained from a non-equilibrium capillary
electrophoresis method. The dissociation equilibrium constant
reported by these authors is between 0.3 and 0.9 mM. This
different value may be due to the fact that we measure the binding
of Tau to an immobilized DNA sample, or to the different size of
the molecule selected as a source on DNA: small oligonucleotides
in the experiments of Krylova et al, in contrast to calf thymus
DNA used in our measurements. Of course, both different
experimental conditions might contribute to the different equilib-
rium constants obtained.
The neuronal concentration of Tau is about 2 mM [48].
According to the Kd values reported here for the DNA interaction
with Tau, this concentration would be high enough to saturate
reversibly the potential DNA-sites available in vivo. The activity of
different types of kinases might additionally affect Tau residues
involved in DNA binding. Sf9 cells can be considered as a good
model to simulate the phosphorylation extent of Tau. Tau
phosphorylation sites associated to Alzheimer’s disease have been
classified into two categories, the KXGS and the SP/TP motifs
[49]. Phosphorylation profile of Tau in transfected Sf9 cells has
been shown to be similar to that of neuronal cells [38]. Our results
show that phosphorylation due to endogenous kinases of Sf9 cells
somehow induces changes in Tau which alter Tau binding to
DNA, in agreement with the lack of colocalization with condensed
chromosomes shown in Figure 1 above. Therefore, Tau phos-
phorylation might regulate the availability of unphosphorylated
Tau to bind DNA in a reversible manner. It has been reported
that heat stress induces Tau dephosphorylation and nuclear
translocation of dephosphorylated Tau, concomitantly with an
increase of Tau-DNA interaction and DNA protection. The full
process is reversed when the insult ceases [24]. This observation is
in agreement with our results showing that binding of dephos-
phorylated Tau to DNA is reversible. According to our
thermodynamic data, changes in the concentration of dephos-
phorylated Tau available to DNA must be the variable determin-
ing the extent of Tau binding and DNA protection. This
phosphorylation-dependent regulation of DNA binding is remi-
niscent of that reported for the Tau-microtubule interaction
regulated also by Tau phosphorylation [41,48].
Tau is an intrinsically disordered protein containing 85
phosphorylatable sites, including 45 serines, 35 threonines and 5
tyrosines [50]. It means that the number of differently phosphor-
ylated forms of the protein (285) by far exceeds the availability of
Tau molecules not only within a neuron but even within the full
Thermodynamics of the DNA-Tau Protein Interaction
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brain, therefore suggesting that phosphorylation might form part
of a subtle mechanism dedicated to modulate protein location and
protein-protein interactions rather than to generate differently
phosphorylated forms having specific properties. Molecular
dynamics calculations have shown how phosphorylation may
induce changes in protein surface hydrophobicity which may be a
determinant of localization to interact with different partners
within the cell [51]. Indeed Tau, like many proteins lacking of a
well defined structure may interact with a large number of
molecular structures. More than thirty partners have been
described [52], including different proteins, DNA and of course
microtubules. It results conceivable that such extended phosphor-
ylation range offered by Tau may be dedicated to supply a fine
modulation of the molecular surface hydrophobicity required to
regulate the Tau location and partnership variability. We have
found that in fact, hydrophobicity must play an important role in
Tau-DNA interaction. Tau protein may adopt a huge number of
conformations in solution, as a consequence of the lack of well-
defined secondary or tertiary structure. Therefore, one would
expect that Tau immobilization on DNA were associated to a
large loss of entropy, i.e. a large and negative value of DS. The
small and positive value found for DS suggests that a large increase
of entropy must parallel the entropy lost derived from the Tau
immobilization on DNA. The release of water molecules as a
consequence of the DNA interaction, with the consequent
availability of translational energy levels, might produce that
entropy increase. This positive hydrophobic contribution to the
entropy change would compensate the negative contribution
associated to the Tau immobilization. The result is a small value
for the change of entropy, DS, and, according to the relationship
DH = DG + TDS, a small value of enthalpy, DH, and the
consequent small influence of temperature on the equilibrium
constant, according to the Van’t Hoff equation. This hypothetical
hydrophobic contribution to the Tau-DNA interaction would be
in agreement with the role that hydrophobicity has been reported
to play in the binding of Tau to microtubules, as well as in the
Tau-Tau interactions leading to the paired helical filaments
formation. Electrophoretic mobility assays of DNA in the presence
of truncated forms of Tau show that the microtubule binding
domain (MTBD) of Tau contributes to the DNA interaction [23].
The MTBD has also been involved in the self-assembling of Tau
[53–55]. Although Tau protein has a low content of hydrophobic
residues, two hydrophobic stretches can be found at the beginning
of the R2 and R3 repetitions forming part of the MTBD, and
hydrophobic interactions have been proposed to play a major role
in Tau-Tau interaction and fibrils formation [56,57].
Tau spontaneously forms small oligomers, protofibrils and
fibrillar fragments [58]. Reversibility of Tau-DNA interaction was
lost two months after purification. The binding was then mostly
irreversible, concomitantly with the process of aggregation. Under
these conditions Tau would remain irreversibly bound to DNA in
a way that is independent of heat/oxidative insults. On the other
hand, massive phosphorylation of Tau, besides depleting the
available normal tau in the neuron by sequestering it [59], would
prevent it from nuclear translocation and the consequent DNA
protection. Protein aggregation and massive phosphorylation are
the two main hallmarks found in Tau protein linked to
tauophaties, among which the most known is Alzheimer’s disease.
If not a coincidence, one would conclude that both Tau
modifications might contribute to the onset of these neurological
disorders by impairing the reversible Tau-DNA interaction and
leading to a Tau-induced DNA deregulation.
Materials and Methods
Chemicals/Reagents
DNA from calf thymus (activated type XV), unfractionated
whole histone from calf thymus (type II-A), poly-L-Lysine, heparin
and hepes were from Sigma (St. Louis, MO, USA). SPR gold
sensorchips were from Xantec Bioanalytics (Dusseldorf, Germany).
PHF-1 antibody was kindly donated by Dr. Davies (Albert Einstein
College of Medicine, NY, USA). According to residue numbering
of the longest human Tau isoform (441 aa), PHF-1 antibody react
with Tau when serines 396 and 404 are phosphorylated. Total tau
protein was detected with Tau-5 antibody from Abcam (Cam-
bridge, MA, USA). Unless otherwise indicated, all experiments
were carried out in a neutral running buffer composed of 10 mM
Hepes, 0.1 M NaCl, pH 7.
Cell culture HEK 293 Tau cells and immunofluorescence
analysis
HEK 293 Tau expressing cells (expressing Tau 3R isoform, a
kind gift from Dr. Miguel Medina) were grown in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% fetal
bovine serum, 2 mMGlutamine, 1 mM Piruvate, 100 U/mL
penicillin, 100 U/mL streptomycin and 0.2 mg/mL Zeocin in a
humidified atmosphere of 5% CO2/95% air at 37 uC. Prolifer-
ating HEK 293 Tau expressing cells were plated on glass
coverslips coated with 1 mg/mL poly-L-lysine, maintained in the
same culture medium for 24 hours. For immunofluorescence
analysis HEK cells were fixed with 4% paraformaldehyde for
20 min at 37 uC and then washed with PBS. Fixed cells were
incubated with 1 M glycine for 30 min and then permeabilized
with 0.2% Triton X-100 in PBS for 5 min at room temperature.
The coverslips were blocked with 1% BSA/PBS for 1 hour at
room temperature and incubated in primary antibodies (PHF-1 or
Tau-5 1/100) in 1% BSA, in PBS, for 1 hour at room
temperature. After washing 3 times with PBS, the secondary
antibodies were incubated for 1 hour at room temperature. To-
pro-3 1mM (Invitrogen, Carlsbad, CA, USA) staining to label
nuclei was performed 10 minutes before finishing secondary
antibody incubation. Finally, the coverslip were washed 3 times
with PBS and once with H2O, and mounted with FluorSave
Reagent (Calbiochem, La Jolla, CA, USA). Fluorescence micros-
copy was used to measure fluorescence intensity. After staining
with PHF-1 antibody, cells were observed on a Zeiss Axiovert 200
fluorescent microscope (Carl Zeiss MicroImaging, Thornwood,
NY, USA). PHF-1 antibody fluorescence images were captured
through a 1006 lens on a high resolution CCD camera (SPOT-
RT Sliders, Diagnostic Instrument Inc, MI, USA).
Tau purification
The detailed purification procedure of the unphosphorylated
longest human Tau isoform, (hTau 42) has been described in a
previous contribution from this laboratory [43]. After expression
in E.coli BL21 (DE3), Tau protein was purified from the
supernatant resulting from bacteria sonication and centrifugation.
The protocol used was based on that described by Lindwall and
Cole [60], which makes use of the heat-and acid-stability of Tau,
together with its insolubility in 25% of glycerol solutions. Tau was
stored at 220 uC in a buffer composed of Hepes 10 mM, NaCl
100 mM and EDTA 1 mM, pH 7. All measurements were carried
out after room-temperature incubation for the time period
indicated for each experiment. The isolated protein was charac-
terized by electrophoresis, UV-absorbance spectroscopy, and
Western blot. Tau protein concentration was obtained by using
an extinction coefficient eM = 7700M
21cm21 at 280 nm [61].
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Expression and purification of phosphorylated Tau
protein
Tau protein, phosphorylated on at least Ser 202, Thr 205 and
Thr 212, Ser 214 as shown by antibodies AT8 and AT100,
respectively [62], was obtained from an insect cell culture infected
with baculoviruses expressing the longest human Tau isoform of
441 amino acids. Sf9 cells were grown at 27 uC in 35 mm dishes,
in fetal bovine serum (Invitrogen, Carlsbad, USA) with antibiotics
(penicillin and streptomycin). Monolayer cultures of Sf9 cells (36
107/mL) were infected with baculoviruses encoding Tau-42 cDNA
and then incubated for 72 h at 27 uC without CO2 from the time
of infection. Infected cells were suspended in 1 mL of 0.1 M Tris,
100 mM NaCl, 1 mM EGTA, 0.5 mM MgCl2, 1 mM sodium
orthovanadate, 2.5 mM sodium pyrophosphate, 10 mM glycero-
phosphate, 100 nM okadaic acid and 0.25 mM PMSF, pH 7.5,
and sonicated 265 min on ice. The homogenate was centrifuged
at 10000 g for 30 minutes and the supernatant boiled for
15 minutes. After centrifugation under the same conditions, 50%
saturated ammonium sulphate was added to the supernatant and
incubated overnight at 4uC to precipitate Tau protein. Pellet
collected after centrifugation was suspended in 1 mL PBS and
dialyzed against 0.1 M Mes, 2 mM EGTA, 0.5 mM MgCl2,
pH 6.7. Purity of both forms of Tau, phosphorylated and
unphosphorylated, was verified by electrophoresis (see Supporting
information). UV absorbance spectra were obtained from both
forms, showing maxima within the range of 270–280 nm (Figures
S1 and S2 in File S1).
Surface Plasmon Resonance
Plasmon resonance has been obtained by means of a homemade
experimental set-up based on the proposals of Kretschmann and
Raether [63], following the description made by Liedberg et al
[64], as it has been described in previous reports [46,65,66]. This
technique monitors macromolecular interactions taking place at
the interface between a solid (usually gold) surface and a buffered
solution. One of the two interacting partners has to be
immobilized on the gold surface, while the second one flows
through a cell, one wall of which is the metallic solid surface. A
monochromatic laser radiation (632.8 nm) from a He-Ne laser is
then directed upon the interface, under total reflection conditions.
Interaction between the immobilized molecules and those flowing
through the cell produces changes in the interface refraction index,
which, in turn, provokes changes in the light reflected intensity,
therefore supplying a physical signal to follow the interaction in
real time.
The gold surface is covered by a three layer structure composed
of two polylysine layers bound to each other by a polyanionic layer
of heparin in the middle. The first polylysine layer is bound to
gold, while the second one is exposed to the solvent [46]. This
three layer structure houses the immobilized partner by interacting
with the external polylysine layer, and prevents biological
molecules from direct contact with gold. It is stable at neutral
pH and is easily rebuilt by changing the pH value from neutral to
basic, therefore allowing for consecutive experiments using the
same experimental set-up for different interaction experiments.
The simplest mechanism describing the reversible interaction of
Tau protein with DNA immobilized on the PHP activated gold
surface (DNAi) is:
DNAizTau/?
k1
k-1
DNAi-Tau ½1
The differential equation defining both reversible steps is:
v:
dC(DNAi-Tau)
dt
~k1C(DNAi)½Tau{k{1C(DNAi-Tau) ½2
where [Tau] stands for the Tau protein concentration in the
solution running through the flow cell. C(DNAi) and C(DNAi-Tau)
stand for the surface concentration of immobilized DNA on the
PHP activated surface and the DNA-Tau complex respectively.
Following equation [1],
C DNAið Þ~Cmax DNAi-Tauð Þ{C DNAi-Tauð Þ ½3
where Cmax(DNAi-Tau) stands for the maximal surface
concentration of Tau bound to immobilized DNA. As mentioned
above, the consequence of the Tau binding on DNA is an increase
of reflectance, which will be proportional to the surface
concentration of Tau bound to DNA (see reference [67] for
details):
R~aC(DNAi-Tau) ½4
Rmax~aCmax(DNAi-Tau) ½5
Substituting equations [3], [4] and [5] into the kinetic equation
[2] yields:
dR
dt
~k1 Tau½ Rmax(k1 Tau½ zk{1)R ½6
Tau protein is constantly supplied by the flow. Its concentration
may, therefore, be considered constant. Consequently, under these
pseudo-first order conditions, a plot of dR/dt versus R must be a
straight line, the slope of which corresponds to (k1 [Tau] + k-1).
The last expression yields the k1 value after knowing k-1. This
constant was obtained from the first-order fitting of the
dissociation complex as probed at real time by the decreasing
reflectance measured when Tau protein solution was substituted
by running buffer.
The equilibrium constant for the binding of Tau on the
immobilized DNA comes defined by:
Keq~
C(DNAi-Tau)
C(DNAi)½Tau ½7
The saturation fraction, Y, of the sensor surface comes given by:
Keq~
C(DNAi-Tau)
Cmax (DNAi-Tau)
~
C(DNAi-Tau)
C(DNAi-Tau)zC(DNAi)
½8
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Solving equation [7] for C(DNAi-Tau) and substituting
equation into [8] renders:
Y~
KeqC(DNAi)½Tau
KeqC(DNAi)½TauzC(DNAi)~
Keq½Tau
Keq½Tauz1 ½9
Rearranging,
Y
½Tau
½Tauz 1
Keq
½10
Equation [10] is the Langmuir-like hyperbolic equation
describing the binding of a ligand, Tau, on a set of independent
binding sites on the immobilized DNA.
The equilibrium values for Y can be easily obtained making use
of equations [4] and [5]
Y~
C(DNAi-Tau)
Cmax (DNAi-Tau)
~
R
Rmax
½11
Unless otherwise indicated, values following the 6 symbol
represent the standard error of the data as obtained for a linear
fitting.
Supporting Information
File S1 SPR immobilization upon polylyisine, SDS-
PAGE and UV spectra of phosphorylated/unphosphory-
lated Tau protein.
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